论文部分内容阅读
目的:评价丙卡特罗联合氯雷他定治疗咳嗽变异性哮喘。方法:58例咳嗽变异性哮喘的患者随机分为对照组和观察组。对照组28例,给予沙丁胺醇联合酮替芬;观察组30例,给予丙卡特罗联合氯雷他定。结果:丙卡特罗组在症状改善上比沙丁胺醇组更明显,两组比较有统计学差异(P<0.05)。结论:丙卡特罗联合氯雷他定治疗咳嗽变异性哮喘有较好疗效。
OBJECTIVE: To evaluate the efficacy and safety of procateral and loratadine in the treatment of cough variant asthma. Methods: Fifty-eight patients with cough variant asthma were randomly divided into control group and observation group. In the control group, 28 patients were given salbutamol combined with ketotifen; 30 patients in the observation group were given procaterol combined with loratadine. Results: Procaterol group was more obvious than albuterol group in symptom improvement, there was significant difference between the two groups (P <0.05). Conclusion: Procaterol and loratadine are effective in treating cough variant asthma.